MedicaidJune 9, 2025
Clinical Criteria updates
Effective July 11, 2025
Summary: The Pharmacy and Therapeutics (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits.
Visit our Clinical Criteria page to find specific policies. For questions or additional information, email Druglist@carelon.com.
See the explanation/definition for each category of Clinical Criteria below:
- New: newly published criteria
- Revised: addition or removal of medical necessity requirements, new document number
Please share this notice with other members of your practice and office staff.
Note:
- The Clinical Criteria listed below apply only to the medical drug benefits contained within the member’s medical plan. This does not apply to pharmacy services.
- This notice is meant to provide information on new or revised criteria that have been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.
Effective date | Clinical Criteria number | Clinical Criteria title | Status |
July 11, 2025 | CC-0282 | Onapgo (apomorphine subcutaneous solution) | New |
July 11, 2025 | CC-0149 | Select Clotting Agents for Bleeding Disorders | Revised |
July 11, 2025 | CC-0037 | Kanuma (sebelipase alfa) | Revised |
July 11, 2025 | CC-0159 | Scenesse (afamelanotide) | Revised |
July 11, 2025 | CC-0245 | Izervay (avacincaptad pegol) | Revised |
July 11, 2025 | CC-0197 | Jemperli (dostarlimab-gxly) | Revised |
July 11, 2025 | CC-0106 | Erbitux (cetuximab) | Revised |
July 11, 2025 | CC-0027 | Denosumab | Revised |
July 11, 2025 | CC-0066 | Monoclonal Antibodies to Interleukin-6 | Revised |
July 11, 2025 | CC-0002 | Colony Stimulating Factor Agents | Revised |
July 11, 2025 | CC-0078 | Orencia (abatacept) | Revised |
CarelonRx, Inc. is a separate company providing utilization review services on behalf of the health plan.
Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
NVBCBS-CD-083836-25-CPN83640
To view this article online:
Visit https://providernews.anthem.com/nevada/articles/clinical-criteria-updates-25593
Or scan this QR code with your phone